TGF-β1 slows the growth of pathogenic myofibroblasts through a mechanism requiring the focal adhesion protein, Hic-5

Journal of Investigative Dermatology

Volumn 128, Issue 2, 2008, Pages 280-291

  Dabiri, Ganary ^a   Tumbarello, David A ^b   Turner, Christopher E ^b   Van De Water, Livingston ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; FOCAL ADHESION KINASE; PROTEIN HIC 5; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; SIGNAL PEPTIDE; TGFB1I1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC SCAR; MYOFIBROBLAST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCAR FORMATION; CELL CULTURE; CELL CYCLE; CELL DIVISION; FIBROBLAST; FOCAL ADHESION; GENE EXPRESSION; GENETICS; INJURY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN;

AUTOCRINE COMMUNICATION; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; CICATRIX, HYPERTROPHIC; CYCLIN A; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FIBROBLASTS; FOCAL ADHESIONS; GENE EXPRESSION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; RNA, SMALL INTERFERING; SKIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 38149081248     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700975     Document Type: Article

References (30)

1. Abe M, Harpel J, Metz C, Nunes I, Loskutoff D, Rifkin D (1994) An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 216: 276-84
2. Brown M, Turner C (2004) Paxillin: adapting to change. Physiol Rev 84: 1315-39
3. Campaner A, Ferreira L, Gragnani A, Bruder J, Cusick J, Morgan J (2006) Upregulation of TGF-β1 expression may be necessary but is not sufficient for excessive scarring. J Invest Dermatol 126:1168-76
4. Dabiri G, Campaner A, Morgan J, Van De Water L (2006) A TGF-β1-dependent autocrine loop regulates the structure of focal adhesions in hypertrophic scar fibroblasts. J Invest Dermatol 126:963-70
5. Desmouliere A, Redard M, Darby I, Gabbiani G (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146:56-66
6. Ehrlich H, Desmouliere A, Diegelmann R, Cohen I, Compton C, Garner W et al. (1994) Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145:105-13
7. Feng X, Derynck R (2005) Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol 21:659-93
8. Grinnell F (1994) Fibroblast, myofibroblast, and wound contraction. J Cell Bio 124:401-4
9. Hagmann J, Grob M, Welman A, Van-Willigen G, Burger M (1998) Recruitment of the LIM protein hic-5 to focal contacts of human platelets. J Cell Sci 111:2181-8
10. Hu P, Datto M, Wang X (1998) Molecular mechanisms of transforming growth factor-β signaling. Endocr Rev 19:349-63
11. Huang S, Huang J (2005) TGF-β control of cell proliferation. J Cell Biochem 96:447-62
12. Lal B, Saito S, Pappas P, Padberg FJ, Cerveira J, Hobson-II R et al. (2003) Altered proliferative responses of dermal fibroblasts to TGF-β1 may contribute to chronic venous stasis ulcer. J Vasc Surg 37:1285-93
13. Moulin V, Larochelle S, Langlois C, Thibault I, Lopez-Valle C, Roy M (2004) Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol 198:350-8
14. Moustakas A, Heldin C (2005) Non-Smad TGF-β signals. J Cell Sci 118: 3573-84
15. Ravitz M, Wenner C (1997) Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-β. Adv Cancer Res 71:165-207
16. Roberts A, Tian F, Byfield S, Stuelten C, Ooshima A, Saika S et al. (2006) Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 17:19-27
17. Scott P, Ghahary A, Tredget E (2000) Molecular and cellular aspects of fibrosis following thermal injury. Hand Clin 16:271-87
18. Shibanuma M, Kim-Kaneyama J, Ishino K, Sakamoto N, Hishiki T, Yamaguchi K et al. (2003) Hic-5 communicates between focal adhesions and the nucleus through oxidant-sensitive nuclear export signal. Mol Biol Cell 14:1158-71
19. Shibanuma M, Kim-Kaneyama J, Sato K, Nose K (2004) A LIM protein, Hic-5, functions as a potential coactivator for Sp1. J Cell Biochem 91: 633-45
20. Shibanuma M, Mashimo J, Kuroki T, Nose K (1994) Characterization of the TGF β1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence. J Biol Chem 269:26767-74
21. Singer A, Clark R (1999) Cutaneous wound healing. New Engl J Med 341: 738-46
22. Thomas S, Hagel M, Turner C (1999) Characterization of a focal adhesion protein, Hic-5, that shares extensive homology with paxillin. J Cell Sci 112:181-90
23. Thornton S, Por S, Walsh B, Penny R, Breit S (1990) Interaction of immune and connective tissue cells: I. The effect of lymphokines and monokines on fibroblast growth. J Leukoc Biol 47:312-20
24. Tomasek J, Gabbiani G, Hinz B, Chaponnier C, Brown R (2002) Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat Rev Mol Cell Biol 3:349-63
25. Tredget E, Nedelec B, Scott P, Ghahary A (1997) Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 77:701-30
26. Tredget E, Wang R, Shen Q, Scott P, Ghahary A (2000) Transforming growth factor-β mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-α and IFN-γ in vitro and in vivo. J Interferon Cytokine Res 20:143-51
27. Tumbarello D, Brown M, Hetey S, Turner C (2005) Regulation of paxillin family members during epithelial-mesenchymal transformation: a putative role for paxillin delta. J Cell Sci 118:4849-63
28. Tumbarello D, Turner C (2007) Hic-5 contributes to epithelial-mesenchymal transformation through a RhoA/ROCK-dependent pathway. J Cell Physiol 211:736-47
29. Yuminamochi T, Yatomi Y, Osada M, Ohmori T, Ishii Y, Nakazawa K et al. (2003) Expression of the LIM proteins paxillin and Hic-5 in human tissues. J Histochem Cytochem 51:513-21
30. Zhang H, Phan S (1999) Inhibition of myofibroblast apoptosis by transforming growth factor β(1). Am J Respir Cell Mol Biol 21:658-65